[ Anaconda BioMed raises $16.83M in Series A ]

Anaconda BioMed has raised $16.83 million in Series A funding.

Founded in 2015, Anaconda BioMed is a a pre-clinical stage medical device company focused on the development of the next generation of neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS).

The company intends to use the funds to advance the development of its solution.

Funding  Series A
Founded  2015
Country  Spain
City  Barcelona, Catalonia
Founder / CEO  Ofir Arad
Deal Size  $16.83M
Investors  Innogest Capital
 Omega Funds
 Ysios Capital
 Banco Sabadell
Previous Investors  Innogest Capital